These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 4168641)

  • 1. Specificity of the Ph1 chromosome.
    Nicoara S; Butoianu E; Brosteanu R
    Lancet; 1967 Dec; 2(7529):1312-3. PubMed ID: 4168641
    [No Abstract]   [Full Text] [Related]  

  • 2. [Chronic myeloproliferative diseases. Clinical and cytogenetic study].
    Fernández Rodríguez MN
    Sangre (Barc); 1971; 16(2):159-84. PubMed ID: 5282697
    [No Abstract]   [Full Text] [Related]  

  • 3. Chromosome studies in potentially leukaemic myeloid disorders.
    Jensen MK
    Acta Med Scand; 1968 Jun; 183(6):535-42. PubMed ID: 5249175
    [No Abstract]   [Full Text] [Related]  

  • 4. Chromosome abnormalities in the myeloproliferative disorders.
    Dewald GW; Wright PI
    Semin Oncol; 1995 Aug; 22(4):341-54. PubMed ID: 7638632
    [No Abstract]   [Full Text] [Related]  

  • 5. Leukaemia cytogenetics.
    Woodliff HJ
    Med J Aust; 1975 Apr; 1(16):495-9. PubMed ID: 124393
    [No Abstract]   [Full Text] [Related]  

  • 6. Cytogenetic studies in chronic myeloproliferative disorders.
    Carbonell F; Ganser A; Heimpel H
    Acta Haematol; 1983; 69(3):145-51. PubMed ID: 6404096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytogenetic studies in Philadelphia chromosome-negative myeloproliferative disorders, particularly polycythaemia rubra vera.
    Lawler SD
    Clin Haematol; 1980 Feb; 9(1):159-74. PubMed ID: 6768481
    [No Abstract]   [Full Text] [Related]  

  • 8. [Nosology and diagnosis of myeloproliferative syndrome].
    Zittoun R; Bernadou A; Zittoun J; Fretault J; Bousser J
    Sem Hop; 1968 Jun; 44(31):2079-84. PubMed ID: 4300452
    [No Abstract]   [Full Text] [Related]  

  • 9. [Primary and secondary thrombocythemia: apropos of 39 cases].
    Bernadou A; Loo H; Prost RJ; Doumenc J; Zittoun R; Bilski-Pasquier G
    Sem Hop; 1968 Jun; 44(31):2092-100. PubMed ID: 4300454
    [No Abstract]   [Full Text] [Related]  

  • 10. Involvement of chromosomes #1 and #11 in three cases with myeloproliferative diseases.
    Schmid E; Köhler J
    Cancer Genet Cytogenet; 1984 Jan; 11(1):121-3. PubMed ID: 6580942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Familial myeloproliferative syndromes. Study of 6 families and review of literature].
    Kaufman S; Brière J; Bernard J
    Nouv Rev Fr Hematol (1978); 1978 Apr; 20(1):1-15. PubMed ID: 353725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chromosomal abnormalities in human neoplasia.
    Sandberg AA; Hossfeld DK
    Annu Rev Med; 1970; 21():379-408. PubMed ID: 4247449
    [No Abstract]   [Full Text] [Related]  

  • 13. Ph1-positive polycythemia vera.
    Nicoară S; Butoianu E; Gingold N
    Med Interne; 1977; 15(1):57-62. PubMed ID: 265077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigations on the chromosome complement in some myeloproliferative disorders.
    Ponti GB; Valentini R; Carrara PM; Eridani S
    Acta Haematol; 1965 Jul; 34(1):36-43. PubMed ID: 4953958
    [No Abstract]   [Full Text] [Related]  

  • 15. Classification of chronic myeloproliferative diseases by bone marrow biopsies. Hematological and cytogenetic findings and clinical course.
    Georgii A; Vykoupil KF; Thiele J
    Bibl Haematol; 1984; (50):41-56. PubMed ID: 6590038
    [No Abstract]   [Full Text] [Related]  

  • 16. [Contribution of cytogenetics in the study of hemopathies].
    Cadotte M
    Union Med Can; 1979 May; 108(5):511-4. PubMed ID: 293076
    [No Abstract]   [Full Text] [Related]  

  • 17. Cytogenetic studies in chronic granulocytic leukaemia.
    Dougan L; Onesti P; Woodliff HJ
    Australas Ann Med; 1967 Feb; 16(1):52-61. PubMed ID: 5230982
    [No Abstract]   [Full Text] [Related]  

  • 18. Duplication of part of chromosome no. 1 in myeloproliferative diseases.
    Gahrton G; Friberg K; Zech L; Lindsten J
    Lancet; 1978 Jan; 1(8055):96-7. PubMed ID: 74592
    [No Abstract]   [Full Text] [Related]  

  • 19. Pathogenetic mechanisms in chronic myeloproliferative disorders: polycythemia vera, essential thrombocythemia, agnogenic myeloid metaplasia, and chronic myelogenous leukemia.
    Tefferi A
    Semin Hematol; 1999 Jan; 36(1 Suppl 2):3-8. PubMed ID: 9930550
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of the frequency of JAK2 (V617F) mutation in different myeloproliferative disorders in Egyptian patients.
    Ebid GT; Ghareeb M; Salaheldin O; Kamel MM
    Int J Clin Exp Pathol; 2015; 8(9):11555-9. PubMed ID: 26617890
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.